Sinopharm Shanghai Plasma-derived Biotherapies

Sinopharm Shanghai Plasma-derived Biotherapies is a specialized biopharmaceutical company focused on the research, development, and manufacturing of plasma-derived medicinal products. As a key subsidiary within the Sinopharm (China National Pharmaceutical Group) ecosystem, specifically under China Tiantan Biological Products, the company operates large-scale plasma fractionation facilities in Shanghai. Its product portfolio includes essential therapies such as human albumin, intravenous immunoglobulin (IVIG), and various coagulation factors used to treat immune deficiencies, hemophilia, and critical care conditions. The company plays a vital role in China's national blood product supply chain, adhering to stringent GMP standards for safety and efficacy. Its operations are integrated into the broader Tiantan Bio platform to ensure a stable and safe supply of life-saving biological treatments.